In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quijano Family

http://

Latest From Quijano Family

Study: FDA Data Shows Endoscope-Related Adverse Events Continue To Rise

A new review of adverse event data found reports tied to each of six endoscope categories rose significantly between 2014 and 2021. For gastroscopes, the rise was an eye-popping 8,630%.

Regulation Safety

Boston Scientific’s Single-Use Exalt-B Bronchoscope To Compete With Ambu’s aScope

Boston Scientific has received 510(k) clearance, launching it into a $1bn market where single-use scopes are increasingly recommended to prevent spread of infections.

Commercial Research & Development

FDA Recommends Broader Use Of Single-Use Bronchoscopes

The single-use scopes should be used in lieu of reprocessed devices when a significant infection risk exists, the US agency says.

Regulation Safety
See All

Company Information

UsernamePublicRestriction

Register